Literature DB >> 24477628

Patient's values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation.

D A Lane1, G Y H Lip.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24477628     DOI： 10.1160/TH14-01-0063

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  11 in total

1.  Selection of Warfarin or One of the New Oral Antithrombotic Agents for Long-Term Prevention of Stroke among Persons with Atrial Fibrillation.

Authors:  Qinmei Xiong; Gregory Y H Lip
Journal:  Curr Treat Options Neurol       Date:  2015-02       Impact factor: 3.598

2.  Optimizing the use of oral anticoagulant therapy for atrial fibrilation in primary care: a pharmacist-led intervention.

Authors:  Mandeep S Virdee; Derek Stewart
Journal:  Int J Clin Pharm       Date:  2017-01-03

3.  Screening for untreated atrial fibrillation in the elderly population: A community-based study.

Authors:  Keitaro Senoo; Arito Yukawa; Takashi Ohkura; Keisuke Shoji; Masao Takigami; Hibiki Iwakoshi; Tetsuro Nishimura; Mitsuko Nakata; Satoshi Teramukai; Satoaki Matoba
Journal:  PLoS One       Date:  2022-06-06       Impact factor: 3.752

4.  Atrial fibrillation: Stroke prevention in atrial fibrillation: can we do better?

Authors:  Deirdre A Lane; Gregory Y H Lip
Journal:  Nat Rev Cardiol       Date:  2016-07-28       Impact factor: 32.419

Review 5.  Recent advances in the understanding and management of atrial fibrillation: a focus on stroke prevention.

Authors:  Farhan Shahid; Eduard Shantsila; Gregory Y H Lip
Journal:  F1000Res       Date:  2016-12-20

6.  Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

Authors:  Peter Brønnum Nielsen; Flemming Skjøth; Mette Søgaard; Jette Nordstrøm Kjældgaard; Gregory Y H Lip; Torben Bjerregaard Larsen
Journal:  BMJ       Date:  2017-02-10

Review 7.  Stroke Prevention in Atrial Fibrillation: Focus on Latin America.

Authors:  Ayrton R Massaro; Gregory Y H Lip
Journal:  Arq Bras Cardiol       Date:  2016-08-11       Impact factor: 2.000

8.  A prospective survey of the persistence of warfarin or NOAC in nonvalvular atrial fibrillation: a COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF).

Authors:  Hyeongsoo Kim; Young Soo Lee; Tae-Hoon Kim; Myung-Jin Cha; Jung Myung Lee; Junbeom Park; Jin-Kyu Park; Ki-Woon Kang; Jaemin Shim; Jae-Sun Uhm; Hyung Wook Park; Eue-Keun Choi; Jin-Bae Kim; Changsoo Kim; Jun Kim; Boyoung Joung
Journal:  Korean J Intern Med       Date:  2019-04-25       Impact factor: 2.884

Review 9.  Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.

Authors:  Hans-Christoph Diener; James Aisenberg; Jack Ansell; Dan Atar; Günter Breithardt; John Eikelboom; Michael D Ezekowitz; Christopher B Granger; Jonathan L Halperin; Stefan H Hohnloser; Elaine M Hylek; Paulus Kirchhof; Deirdre A Lane; Freek W A Verheugt; Roland Veltkamp; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2017-03-21       Impact factor: 29.983

10.  Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey.

Authors:  Monika Kozieł; Stefan Simovic; Nikola Pavlovic; Milan Nedeljkovic; Vilma Paparisto; Ljilja Music; Evgenii Goshev; Anca Rodica Dan; Sime Manola; Zumreta Kusljugic; Elina Trendafilova; Dobromir Dobrev; Gheorghe-Andrei Dan; Gregory Y H Lip; Tatjana S Potpara
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.